Anti-Angiogenesis Drug Discovery and Development Volume 5

Anti-Angiogenesis Drug Discovery and Development Volume 5 image
ISBN-10:

9811432864

ISBN-13:

9789811432866

Author(s): Rahman, Atta-Ur
Released: Oct 05, 2020
Format: Paperback, 210 pages
to view more data

Description:

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance - many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians.The fifth volume brings together reviews on the following topics:- Targeted therapy for tumor vasculature- Anti-angiogenic therapy for breast and prostate cancers (including information updates on clinical trials)- Microbe-based and other novel antiangiogenesis therapies, including chromene-based agents

Low Price Summary






Top Bookstores


























We're an Amazon Associate. We earn from qualifying purchases at Amazon and all stores listed here.

DISCLOSURE: We're an eBay Partner Network affiliate and we earn commissions from purchases you make on eBay via one of the links above.

Want a Better Price Offer?

Set a price alert and get notified when the book starts selling at your price.

Want to Report a Pricing Issue?

Let us know about the pricing issue you've noticed so that we can fix it.